Brief: Amendments To Protokinetix Aagp® Protocol For Continuation Of Phase 1 Human Trials By The University Of Alberta Submitted To Health Canada

ProtoKinetix

13/07/2020 13:39

July 13 (Reuters) - ProtoKinetix Inc  PKTX.PK :
    * AMENDMENTS TO PROTOKINETIX AAGP® PROTOCOL FOR CONTINUATION
OF
PHASE 1 HUMAN TRIALS BY THE UNIVERSITY OF ALBERTA SUBMITTED TO
HEALTH CANADA

Source text for Eikon:  ID:nBw76sSPZa 
Further company coverage:  PKTX.PK 

 (Reuters.Briefs@thomsonreuters.com)